Product Detail
N-Boc Palbociclib-d4
Palbociclib Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Palbociclib
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
N-Boc Palbociclib-d4 Product Information
N-Boc Palbociclib-d4 is listed under Stable Isotopes. It is associated with Palbociclib and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103846.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
N-Boc Palbociclib-d4
CAS No.
1651214-74-2(Unlabelled)
CAT No.
CS-T-103846
Molecular Formula
C₂₉H₃₃D₄N₇O₄
Molecular Weight
551.67
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
CC1=C(C(C)=O)C(N(C2CCCC2)C3=NC(NC4=NC=C(N5CC([2H])([2H])N(C(OC(C)(C)C)=O)C([2H])([2H])C5)C=C4)=NC=C13)=O
IUPAC Name
4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-pPiperazinecarboxylic Acid 1,1-Dimethylethyl Ester-d4
Hazard Compound
Refer MSDS for complete information.
Description
Overview
Isotope labelled N-Boc Palbociclib is a protected Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Synonyms
4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-pPiperazinecarboxylic Acid 1,1-Dimethylethyl Ester-d4
Application Notes
Isotope labelled N-Boc Palbociclib is a protected Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
References
Finn, R., et al.: Breast Cancer Res., 11, 5 (2009);
Related Palbociclib Products
Palbociclib-d4 Hydrochloride
Palbociclib Impurity 59
Palbociclib Impurity 22
Palbociclib Impurity 15
N-Nitroso Palbociclib 3
![tert-Butyl 4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) chemical structure](https://structures.clearsynth.com/CS-MM-62870.png)
tert-Butyl 4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)
Palbociclib Hydrobromide
Palbociclib Chlorobromo Impurity
Palbociclib Maleic Acid Adduct
